Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2011

01-09-2011 | Original Article

Continuous Peritoneal Drainage of Large-Volume Ascites

Authors: David H. Van Thiel, Christopher M. Moore, Moises Garcia, Magdalena George, Abdul Nadir

Published in: Digestive Diseases and Sciences | Issue 9/2011

Login to get access

Abstract

Background

With the increasing population of individuals with cirrhosis, many of whom are not liver transplant candidates, large volume paracentesis as a medical therapy for ascites resistant to diuretic therapy has become increasingly utilized.

Aim

To determine the safety and efficacy of continuous peritoneal drainage of large-volume ascites in Child Class-C cirrhosis. Subjects with no current clinical or laboratory findings of spontaneous bacterial ascites were studied. Each had a complete medical evaluation to document the etiology and severity of their liver disease as well as the identification of any confounding medical illness. A triple-phase abdominal CT of the abdomen was obtained in each individual to rule out any hepatoma. Upon completion of the above, a pericardiocentesis catheter was placed in the abdomen using the Seldinger technique and the ascites was drained continuously (to gravity) until no additional ascitic fluid could be removed or the total time of drainage was 72 h. The patient’s weight, volume of ascitic fluid removed, ascitic fluid cell counts, ascitic fluid cultures, complete blood count and comprehensive metabolic profile were obtained immediately before and after the peritoneal catheter was removed.

Results

HCV cirrhosis accounted for 12 cases and alcoholic liver disease accounted for 8 cases (half the total of 40 cases), with 6 other diseases accounting for the remaining half. The ascitic fluid was drained continuously for 2.5 ± 0.08 days, with a removal of 13.3 ± 0.5 l of ascitic fluid. No clinically significant change in the serum creatinine or ascitic fluid cells count occurred as a result of the procedure. The adverse effects of the procedure were minimal. 63% of the patients experienced some mild discomfort at the catheter insertion site, or local abdominal pain just prior to the removal of the catheter. Two patients developed a small abdominal wall hematoma that required no therapy. No patients experienced peritoneal hemorrhage, infection or renal dysfunction.

Conclusion

(1) Continuous large-volume peritoneal drainage by gravity is safe and effective; (2) if the procedure is limited 72 h, no cases of ascitic fluid contamination/infection occur; and (3) it reduces the time between subsequent paracentesis based upon historical data.
Literature
1.
go back to reference Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–856.PubMedCrossRef Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 2004;39:841–856.PubMedCrossRef
2.
3.
go back to reference Sungaila I, Bartle WR, Walker SE, et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology. 1992;102:1680–1685.PubMed Sungaila I, Bartle WR, Walker SE, et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology. 1992;102:1680–1685.PubMed
5.
6.
go back to reference Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large volume paracentesis in patients with cirrhosis and diuretic resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large volume paracentesis in patients with cirrhosis and diuretic resistant ascites. Am J Gastroenterol. 1997;92:394–399.PubMed
7.
go back to reference Runyon BA. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume. Am J Gastroenterol. 1997;92:371–373.PubMed Runyon BA. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume. Am J Gastroenterol. 1997;92:371–373.PubMed
8.
go back to reference Rössle M, Ochs A, Gülberg V, et al. A comparison of paracentesis and transjuglar intra-hepatic portosystemic shunting in patients with ascites. N Eng J Med. 2000;342:1745–1747.CrossRef Rössle M, Ochs A, Gülberg V, et al. A comparison of paracentesis and transjuglar intra-hepatic portosystemic shunting in patients with ascites. N Eng J Med. 2000;342:1745–1747.CrossRef
9.
go back to reference Boyer TD, Haskal ZJ. The role of transjugualr intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.PubMedCrossRef Boyer TD, Haskal ZJ. The role of transjugualr intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.PubMedCrossRef
10.
go back to reference Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700–1710.PubMedCrossRef Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700–1710.PubMedCrossRef
11.
go back to reference Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829–835.PubMedCrossRef Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829–835.PubMedCrossRef
12.
go back to reference Nadir A, Van Thiel DH. Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayb Med Coll. 2010;22:37–41. Nadir A, Van Thiel DH. Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayb Med Coll. 2010;22:37–41.
13.
go back to reference Tito L, Gines P, Arroyo V, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146–151.PubMed Tito L, Gines P, Arroyo V, et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology. 1990;98:146–151.PubMed
14.
go back to reference Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25:984–986.PubMedCrossRef Sakai H, Sheer TA, Mendler MH, Runyon BA. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25:984–986.PubMedCrossRef
15.
go back to reference Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.PubMedCrossRef Grabau CM, Crago SF, Hoff LK, et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.PubMedCrossRef
16.
go back to reference McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.PubMedCrossRef McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.PubMedCrossRef
17.
go back to reference Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366–368.PubMed Webster ST, Brown KL, Lucey MR, Nostrant TT. Hemorrhagic complications of large volume abdominal paracentesis. Am J Gastroenterol. 1996;91:366–368.PubMed
18.
go back to reference Van Thiel DH, Hassanein T, Gurakar A, et al. Liver transplantation after an acute episode of spontaneous bacterial peritonitis. Hepatogastroenterology. 1996;43:1584–1588.PubMed Van Thiel DH, Hassanein T, Gurakar A, et al. Liver transplantation after an acute episode of spontaneous bacterial peritonitis. Hepatogastroenterology. 1996;43:1584–1588.PubMed
Metadata
Title
Continuous Peritoneal Drainage of Large-Volume Ascites
Authors
David H. Van Thiel
Christopher M. Moore
Moises Garcia
Magdalena George
Abdul Nadir
Publication date
01-09-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1792-x

Other articles of this Issue 9/2011

Digestive Diseases and Sciences 9/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.